Heidrun Irschik-Hadjieff
Director Ejecutivo en Shire Deutschland GmbH .
Origen de la red de primer grado Heidrun Irschik-Hadjieff.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Shire Deutschland GmbH
Shire Deutschland GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Takeda Pharma Vertrieb GmbH & Co. KG
Takeda Pharma Vertrieb GmbH & Co. KG Drugstore ChainsRetail Trade Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharma Vertrieb GmbH & Co. KG is a German company that sells pharmaceutical products. The company is based in Berlin, Germany. The CEOs are Roland Kurney, Heidrun Irschik-Hadjieff. The company was founded in 1781.
1
| Subsidiary | Drugstore Chains | 1 |
Shire Deutschland Investments GmbH
Shire Deutschland Investments GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland Investments GmbH develops and markets pharmaceutical products. The company is based in Berlin, Germany. The CEOs of the German company are Roland Kurney, Heidrun Irschik-Hadjieff.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Heidrun Irschik-Hadjieff a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
DANONE | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
REVVITY, INC. | Medical Specialties | Director/Board Member | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member | |
Bacardi & Co. Ltd.
Bacardi & Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Bacardi & Co. Ltd. engages in the production and distribution of alcoholic beverages. It offers products that include rum, wine, whisky, tequila, vodka, cocktail mixes and distilled spirits. The firm is a subsidiary of Bacardi Ltd. The company is headquartered in Nassau, Bahamas. | Beverages: Alcoholic | Director of Finance/CFO | |
SANOFI | Biotechnology | General Counsel Corporate Officer/Principal | |
SARcode Bioscience, Inc.
SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Pharmaceuticals: Major | Founder | |
SHIRE | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
INDIVIOR PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
EUROMICRON AG | Information Technology Services | Chairman | |
Zentiva Group as
Zentiva Group as Pharmaceuticals: MajorHealth Technology Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic. | Pharmaceuticals: Major | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Graduate Degree | |
KfW IPEX-Bank GmbH
KfW IPEX-Bank GmbH Regional BanksFinance KfW IPEX-Bank GmbH provides project, corporate, trade and export finance services. It offers medium to long-term financing solutions to support the German and European economy. The firm finances economic and social infrastructure in Europe, helps to secure the supply of raw materials and supports the realization of environmental and climate protection projects - all over the world. It finances for ships, aircraft and railroad vehicles as well as for investments in the expansion of airports and seaports. The firm provides tailor-made financing solutions for energy and environmental protection projects. The company was founded in 1948 and is headquartered in Frankfurt, Germany. | Regional Banks | Director/Board Member | |
State University of New York at Buffalo | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
The University of Colorado | College/University | Director/Board Member | |
Georgetown University | College/University | Graduate Degree | |
The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree | |
WHU-Otto Beisheim School of Management | College/University | Masters Business Admin | |
Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG
Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG Insurance Brokers/ServicesFinance Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG is a German company that provides insurance services. The private company is based in Frankfurt, Germany. and has subsidiaries in Germany. Jürgen Rings has been the CEO of the company since 2018. | Insurance Brokers/Services | Chairman | |
MAGFORCE AG | Medical Specialties | Investor Relations Contact | |
Hoechst Trevira GmbH & Co. KG
Hoechst Trevira GmbH & Co. KG Financial ConglomeratesFinance Part of Sanofi, Hoechst Trevira GmbH & Co. KG is a German company that provides financial services. The company is based in Frankfurt, Germany. The CEOs are Fabrizio Guidi, Evelyne Freitag. The company was founded in 1994. | Financial Conglomerates | Chief Executive Officer | |
SuppreMol GmbH
SuppreMol GmbH Pharmaceuticals: MajorHealth Technology SuppreMol GmbH engages in the development and use of active substances for the therapy of autoimmune diseases and allergies, as well as the research on and development of medicinal products. It also produces medicines through licensed manufacturers. The products are supplied via pharmaceutical wholesale. The company was founded by Robert Huber, Uwe Jacob, and Peter Sondermann in 2002 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Goodyear Germany GmbH
Goodyear Germany GmbH Automotive AftermarketConsumer Durables Goodyear Dunlop Tires Germany GmbH manufactures and supplies car, truck, motorcycle and racing tires. Its product technologies encompass tread design, multi-blade system, bead seat system, multi-radius tread and flatter tread profile. The firm is engaged in tire and equipment development and management. The company was founded in 1888 and is headquartered in Hanau, Germany. | Automotive Aftermarket | Chief Executive Officer | |
Pfizer GmbH | Corporate Officer/Principal | ||
Takeda Pharma A/S (DK)
Takeda Pharma A/S (DK) Drugstore ChainsRetail Trade Takeda Pharma A/S operates as a pharmaceutical company that provides medicines and products for hospitals, specialists, and general practitioners. It supplies prescription and non-prescription medicines for oncology and gastroenterology diseases. The company was founded on January 2, 1984 and is headquartered in Taastrup, Denmark. | Drugstore Chains | Chief Executive Officer | |
VEON LTD. | Wireless Telecommunications | Director/Board Member | |
Hoechst GmbH
Hoechst GmbH Pharmaceuticals: MajorHealth Technology Part of Sanofi, Hoechst GmbH is a German company that manufactures and sells drugs. The company is based in Frankfurt, Germany. The CEO of the company is Fabrizio Guidi. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Implandata Ophthalmic Products GmbH
Implandata Ophthalmic Products GmbH Electronic Equipment/InstrumentsElectronic Technology Implandata Ophthalmic Products GmbH develops diagnosis tool for glaucoma therapy. Its technology Pro-IOP is an eye pressure measurement system consists of an implantable micro sensor, responsible for pressure sensing, an external hand held device, which is transferring energy to the micro sensor telemetrically and which is responsible for data read out and storage and a GSM module which can be connected with the hand held device for transfer of measurement data to a database, which can be accessed by the eye doctor in order to get information about the disease status of the patient. The company was founded by Max Georg Ostermeier and Stefan Meyer in January 2010 and is headquartered in Hannover, Germany. | Electronic Equipment/Instruments | Director/Board Member | |
STALLERGENES GmbH
STALLERGENES GmbH Pharmaceuticals: MajorHealth Technology Stallergenes GmbH prepares and provides pharmaceuticals for the treatment of allergies. The firm's products range from diagnostic to allergen immunotherapy. It develops allergen immunotherapy and allergen supplied with highly innovative and individually tailored solutions. The company is headquartered in Kamp-Lintfort, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Takeda GmbH
Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873. | Pharmaceuticals: Major | Chief Executive Officer | |
NEVIS BRANDS INC. | Biotechnology | Director/Board Member | |
CNH INDUSTRIAL N.V. | Trucks/Construction/Farm Machinery | Director/Board Member | |
Georgetown University Law Center | College/University | Corporate Officer/Principal | |
AELIS FARMA | Biotechnology | Director/Board Member | |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Biotechnology | Chief Executive Officer | |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
Rogne Bioscience, Inc.
Rogne Bioscience, Inc. BiotechnologyHealth Technology Rogne Bioscience, Inc. is an American company that focuses on researching and developing biotechnology products. The private company is based in Portola Valley. | Biotechnology | Chief Executive Officer | |
Hoechst Trevira Verwaltungs GmbH
Hoechst Trevira Verwaltungs GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Hoechst Trevira Verwaltungs GmbH is a German company that provides administration and management services. The company is based in Frankfurt, Germany. The CEOs are Fabrizio Guidi, Evelyne Freitag. The company was founded in 1994. | Miscellaneous Commercial Services | Chief Executive Officer | |
Takeda Singen Real Estate GmbH & Co. KG
Takeda Singen Real Estate GmbH & Co. KG Real Estate DevelopmentFinance Takeda Singen Real Estate GmbH & Co. KG provides real estate services. The private company is based in Singen, Germany. The CEOs are Wolfgang Eck, Roland Kurney, Alexander Maechler. The German company was founded in 2015. | Real Estate Development | Chief Executive Officer | |
Global Antibiotic Research & Development Partnership
Global Antibiotic Research & Development Partnership BiotechnologyHealth Technology Global Antibiotic Research & Development Partnership is a Swiss company that is working to combat antibiotic resistance. The non-profit company is based in Geneva, Switzerland. Antibiotic resistance occurs when bacteria no longer respond to treatment, and millions of people suffer from this every year. The company is developing a new initiative called SECURE, which aims to provide access to essential antibiotics and prepare for and respond to pandemics. | Biotechnology | Director/Board Member | |
EUROAPI | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Alemania | 19 |
Estados Unidos | 16 |
Francia | 7 |
Reino Unido | 3 |
Dinamarca | 3 |
Sectorial
Health Technology | 25 |
Consumer Services | 10 |
Finance | 6 |
Consumer Non-Durables | 3 |
Commercial Services | 3 |
Operativa
Director/Board Member | 45 |
Chief Executive Officer | 21 |
Corporate Officer/Principal | 20 |
Chairman | 13 |
Independent Dir/Board Member | 11 |
Las relaciones más conectadas
Insiders | |
---|---|
Sylvie Grégoire | 25 |
Klaus Stöckemann | 14 |
Karen Linehan | 11 |
Tatjana Anni Hilde May | 10 |
Tom Gadek | 9 |
Evelyne Freitag | 8 |
Philippe Luscan | 7 |
Graham Hetherington | 6 |
Roland Kurney | 5 |
Leonhard Terp | 4 |
Uwe Fröhlich | 3 |
Werner Föller | 3 |
Stacy Wiedenmann | 2 |
Karsten Meisloch | 2 |
Matthias Braun | 2 |
- Bolsa de valores
- Insiders
- Heidrun Irschik-Hadjieff
- Conexiones Empresas